Acquiring Company
Zydus Lifesciences
Acquired Company
Sterling Biotech
MumbaiHealth CareMedicalManufacturingBiotechnologyDescription
Zydus Lifesciences has completed the acquisition of the Active Pharmaceutical Ingredient business of Sterling Biotech Limited, as disclosed on 2 November 2026. The deal was governed by a Business Transfer Agreement signed on 17 September 2024, with all conditions precedent and closing adjustments fulfilled. No financial consideration was disclosed in the exchange filing.
Who to call at Zydus Lifesciences, and when
When Zydus Lifesciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Zydus Lifesciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zydus Lifesciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zydus Lifesciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zydus Lifesciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Sterling Biotech?
Sterling Biotech was acquired by Zydus Lifesciences. The deal was reported on November 2, 2026. After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Zydus Lifesciences is privately held and operates in Health Care.
When did Zydus Lifesciences acquire Sterling Biotech?
Zydus Lifesciences's acquisition of Sterling Biotech was reported on November 2, 2026. Zydus Lifesciences has completed the acquisition of the Active Pharmaceutical Ingredient business of Sterling Biotech Limited, as disclosed on 2 November 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sterling Biotech do?
Sterling Biotech is engaged in the manufacturing and sale of fermentation-based API products and gelatine. Post the acquisition by Zydus Lifesciences, it will become a 50:50 joint venture with equal representation on the Board. It is privately held, operating in Manufacturing, and is based in Mumbai.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.